Related Experiment Video
Updated: Jun 2, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
[Variability in blood pressure and arterial hypertension]
1Centrum pro hypertenzi III. interní kliniky 1. Iékarské fakulty UK a VFN Praha. jwidi@lf1.cuni.cz
Insights
Blood pressure variability increases cardiovascular risk, particularly stroke. Certain antihypertensive medications, like calcium channel blockers (CCBs) and ACE-inhibitors, effectively reduce this variability, potentially lowering event risk.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertension management is crucial for preventing cardiovascular complications.
- Blood pressure variability (BPV) is an independent risk factor for stroke and other cardiovascular events.
- The choice of antihypertensive therapy can influence both blood pressure levels and BPV.
Purpose:
- To evaluate the impact of different antihypertensive drug classes on blood pressure variability.
- To assess the predictive value of within-visit BPV for cardiovascular outcomes.
- To inform clinical practice regarding optimal antihypertensive strategies for risk reduction.
Summary:
- Antihypertensive drugs with potent blood pressure-lowering effects and BPV suppression may offer additional cardiovascular protection.
- Calcium channel blockers (CCBs) demonstrate superior reduction in BPV compared to other antihypertensive classes.
- Combining CCBs with ACE-inhibitors shows greater BPV suppression than diuretics with beta-blockers.
- Within-visit BPV, measured via standard deviation coefficient, is a significant predictor of stroke and cardiovascular events.
Impact:
- Findings suggest that targeting BPV with specific antihypertensive agents like CCBs could be a valuable strategy in hypertension management.
- The combination of CCBs and ACE-inhibitors may provide enhanced cardiovascular risk reduction by modulating BPV.
- Within-visit BPV assessment offers a simple yet powerful tool for stratifying stroke and cardiovascular risk in hypertensive patients.
Abstract:
Blood pressure variability in hypertension is an independent risk factor of cardiovascular complications, especially of stroke. Antihypertensive drugs/classes with powerful antihypertensive effect and suppression of blood pressure variability might have additional impact on the cardiovascular risk in clinical practice. Current evidence suggests that calcium channel blockers (CCB) decrease blood pressure variability more than all other antihypertensive classes. Combination of CCB with ACE-inhibitors suppresses blood pressure variability more than diuretics plus beta-blockers. Within-visit blood pressure variability (measured as coefficient of standard deviation) seems to be relatively simple and strong predictor of stroke and cardiovascular events.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension II: Pathophysiology
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
